TAMARA FERNÁNDEZ-CALERO1,2,3,#, IGNACIO LÓPEZ1,#, MARCOS DAVYT1, CORA CHALAR1, RICARDO EHRLICH1,4, MÓNICA MARÍN1,*
BIOCELL, Vol.46, No.11, pp. 2353-2356, 2022, DOI:10.32604/biocell.2022.020966
Abstract The epithelial to mesenchymal transition (EMT) is a cellular program that drives de-differentiation of cells in both physiological and pathological processes. One of the characteristics of cells describing an EMT is the (re)acquisition of a motility capacity that allows them to migrate through the original tissue as well as to other sites in the organism. The molecular mechanisms that control the EMT are rapidly emerging and here we add to the idea that the adaptation required for cells to commit to the EMT includes adjustments of the translation machinery and metabolic pathways to cope with More >